David Charles Lubner - 14 Jun 2022 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Director
Signature
/s/ Rich Segal, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
14 Jun 2022
Net transactions value
$0
Form type
4
Filing time
16 Jun 2022, 17:05:39 UTC
Previous filing
06 Jun 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Stock Option (right to buy) Award $0 +16,911 $0.000000 16,911 14 Jun 2022 Common Stock 16,911 $4.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted to the Reporting Person pursuant to the Issuer's non-employee director compensation policy. The shares underlying the option vest and become exercisable on the earlier of (i) June 14, 2023 or (ii) the Issuer's next annual meeting of stockholders following the grant date, in each case, subject to the Reporting Person's continued service as a director through such date.